EXHIBIT 32.2

                           CERTIFICATION PURSUANT TO
                            18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                 SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Enox Biopharma, Inc. (the "Company")
on Form 10-Q for the period ended March 31, 2009, as filed with the Securities
and Exchange Commission on the date hereof (the "Report"), I, Razi Mizrahi,
Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that, to the best of my knowledge and belief:

     (1)  the Report fully complies with the requirements of Section 13(a) or
          15(d) of the Securities Exchange Act of 1934; and

     (2)  the information contained in the Report fairly presents, in all
          material respects, the financial condition and results of operations
          of the Company.


Date: April 29, 2009                       By: /s/ Razi Mizrahi
                                              ----------------------------------
                                           Name:  Razi Mizrahi
                                           Title: Secretary and Treasurer
                                                  Principal Financial Officer)